แนวทางเชิงปฏิบัติในการวินิจฉัยและดูแลรักษาภาวะหนังศีรษะเป็นขุย
บทคัดย่อ
ภาวะหนังศีรษะเป็นขุยเป็นปัญหาที่พบได้บ่อยในเวชปฏิบัติ และนำมาซึ่งผลกระทบแก่ผู้ป่วยทั้งทางร่างกายและการเข้าสังคม โรคที่พบว่าเป็นสาเหตุได้บ่อยได้แก่ รังแค, โรคผิวหนังอักเสบเซ็บบอเรอิค, สะเก็ดเงิน, โรคกลาก และ ผื่นผิวหนังอักเสบจากการสัมผัส ในปัจจุบันได้มีการศึกษาและวิจัยเพิ่มเติมทั้งในแง่ของการวินิจฉัยโรคและแนวทางการรักษาเพื่อให้ได้ผลการรักษาที่ดีที่สุด โดยในบทความฟื้นฟูวิชาการฉบับนี้ จะรวบรวมข้อมูลที่ทันสมัยทั้งในด้านอาการแสดง การตรวจวินิจฉัย และการรักษาภาวะหนังศีรษะเป็นขุย
เอกสารอ้างอิง
1. Borda LJ, Wikramanayake TC. Seborrheic Dermatitis and Dandruff: A Comprehensive Review. J Clin Investig Dermatol 2015;3.
2. Hay RJ. Malassezia, dandruff and seborrhoeic dermatitis: an overview. Br J Dermatol 2011; 165: 2-8.
3. Blanes M, Belinchon I, Merino E, et al. [Current prevalence and characteristics of dermatoses associated with human immunodeficiency virus infection]. Actas Dermosifiliogr 2010; 101: 702-9.
4. Dunic I, Vesic S, Jevtovic DJ. Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy. HIV Med 2004;5:50-4.
5. Mathes BM, Douglass MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985;13:947-51.
6. Osei-Sekyere B, Karstaedt AS. Immune reconstitution inflammatory syndrome involving the skin. Clin Exp Dermatol 2010;35:477-81.
7. Burton JL, Pye RJ. Seborrhoea is not a feature of seborrhoeic dermatitis. Br Med J (Clin Res Ed). 1983; 286: 1169-70.
8. Tajima M, Sugita T, Nishikawa A, et al. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol 2008;128:345-51.
9. DeAngelis YM, Gemmer CM, Kaczvinsky JR, et al. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J Investig Dermatol Symp Proc 2005;10:295-7.
10. Pierard-Franchimont C, Pierard GE, Arrese JE, et al. Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments. Dermatology 2001;202:171-6.
11. Pierard-Franchimont C, Goffin V, Decroix J, et al. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol 2002;15:434-41.
12. Danby FW, Maddin WS, Margesson LJ, et al. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993;29:1008-12.
13. Gupta AK, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol 2014;28:16-26.
14. Lambert DR, Siegle RJ, Camisa C. Griseofulvin and ketoconazole in the treatment of dermatophyte infections. Int J Dermatol 1989;28:300-4.
15. Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN. Topical antifungals for seborrhoeic dermatitis. Cochrane Database Syst Rev 2015: CD008138.
16. Kastarinen H, Oksanen T, Okokon EO, et al. Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp. Cochrane Database Syst Rev 2014:CD009446.
17. Lebwohl M. Psoriasis. Lancet 2003;361:1197-204.
18. Sola-Ortigosa J, Sanchez-Regana M, UmbertMillet P. [An update on scalp psoriasis]. Actas Dermosifiliogr 2009; 100: 536-43.
19. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patientmembership survey. Arch Dermatol 2001; 137:280-4.
20. Ortonne J, Chimenti S, Luger T, et al. Scalp psoriasis: European consensus on grading and treatment algorithm. J Eur Acad Dermatol Venereol 2009; 23: 1435-44.
21. George SM, Taylor MR, Farrant PB. Psoriatic alopecia. Clin Exp Dermatol 2015;40:717-21.
22. Cockayne SE, Messenger AG. Familial scarring alopecia associated with scalp psoriasis. Br J Dermatol 2001;144:425-7.
23. Kim GW, Jung HJ, Ko HC, et al. Dermoscopy can be useful in differentiating scalp psoriasis from seborrhoeic dermatitis. Br J Dermatol 2011; 164: 652-6.
24. Kibar M, Aktan S, Bilgin M. Dermoscopic findings in scalp psoriasis and seborrheic dermatitis; two new signs; signet ring vessel and hidden hair. Indian J Dermatol 2015;60:41-5.
25. Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol 2006;55:799-806.
26. Iamsumang W, Sriphojanart T, Suchonwanit P. Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus. Case Rep Dermatol 2017;9:51-9.
27. Wang TS, Tsai TF. Managing Scalp Psoriasis: An Evidence-Based Review. Am J Clin Dermatol 2017; 18:17-43.
28. Dermatological Society of Thailand [Internet]. Clinical Practice Guideline for Psoriasis 2011; 2011 [cited 2017 Dec 16]. Available from: https://www.dst.or.th/Physician/Articles/435.29.0/ yYLY4tzYM0.
29. Puig L, Ribera M, Hernanz JM, et al. [Treatment of scalp psoriasis: review of the evidence and Delphi consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology]. Actas Dermosifiliogr 2010; 101: 827-46.
30. Schlager JG, Rosumeck S, Werner RN, et al. Topical treatments for scalp psoriasis. Cochrane Database Syst Rev 2016;2:CD009687.
31. Fotiadou C, Lazaridou E, Sotiriou E, et al. Scalp psoriasis and biologic agents: a retrospective, comparative study from a tertiary psoriasis referral centre. J Eur Acad Dermatol Venereol. 2016; 30: 2091-6.
32. Hay RJ. Tinea Capitis: Current Status. Mycopathologia. 2017; 182: 87-93.
33. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol 2000; 42: 1-20; quiz 1-4.
34. Fuller LC, Barton RC, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol 2014;171:454-63.
35. Ekiz O, Sen BB, Rifaioglu EN, Balta I. Trichoscopy in paediatric patients with tinea capitis: a useful method to differentiate from alopecia areata. J Eur Acad Dermatol Venereol 2014;28:1255-8.
36. Slowinska M, Rudnicka L, Schwartz RA, et al. Comma hairs: a dermatoscopic marker for tinea capitis: a rapid diagnostic method. J Am Acad Dermatol 2008; 59:S77-9.
37. Neri I, Starace M, Patrizi A, Balestri R. Corkscrew hair: a trichoscopy marker of tinea capitis in an adult white patient. JAMA Dermatol 2013;149:990-1.
38. Lacarrubba F, Verzi AE, Micali G. Newly described features resulting from high-magnification dermoscopy of tinea capitis. JAMA Dermatol 2015;151:308-10.
39. Wang HH, Lin YT. Bar code-like hair: dermoscopic marker of tinea capitis and tinea of the eyebrow. J Am Acad Dermatol 2015;72:S41-2.
40. Dermatological Society of Thailand [Internet]. Clinical Practice Guideline Superficial Fungal Infection 2011; 2011 [cited 2017 Dec 16]. Available from: https://www.dst.or.th/Physician/Articles/433.29.0/ 5LNWbWTDDb.
41. Chen X, Jiang X, Yang M, et al. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2016:CD004685.
42. Tey HL, Tan AS, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol 2011;64:663- 70.
43. Koumantaki-Mathioudaki E, DevliotouPanagiotidou D, Rallis E, et al. Is itraconazole the treatment of choice in Microsporum canis tinea capitis? Drugs Exp Clin Res 2005; 31:11-5.
44. Proudfoot LE, Higgins EM, Morris-Jones R. A retrospective study of the management of pediatric kerion in Trichophyton tonsurans infection. Pediatr Dermatol 2011;28:655-7.
45. Hussain I, Muzaffar F, Rashid T, et al. A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Med Mycol 1999;37:97-9.
46. Nenoff P, Kruger C, Paasch U, Ginter-Hanselmayer G. Mycology-an update Part 3: Dermatomycoses: topical and systemic therapy. J Dtsch Dermatol Ges 2015;13:387-410; quiz 441.
47. Kakourou T, Uksal U. Guidelines for the management of tinea capitis in children. Pediatr Dermatol 2010;27:226-8.
48. Goh CL. Eczema of the face, scalp and neck: an epidemiological comparison by site. J Dermatol 1989;16:223-6.
49. Hillen U, Grabbe S, Uter W. Patch test results in patients with scalp dermatitis: analysis of data of the Information Network of Departments of Dermatology. Contact Dermatitis 2007;56:87-93.
50. Knight AG. Pityriasis amiantacea: a clinical and histopathological investigation. Clin Exp Dermatol 1977;2:137-43.
51. McGinley KJ, Leyden JJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in nondandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol 1975;64:401-5.
52. Abdel-Hamid IA, Agha SA, Moustafa YM, EILabban AM. Pityriasis amiantacea: a clinical and etiopathologic study of 85 patients. Int J Dermatol 2003;42:260-4.
2. Hay RJ. Malassezia, dandruff and seborrhoeic dermatitis: an overview. Br J Dermatol 2011; 165: 2-8.
3. Blanes M, Belinchon I, Merino E, et al. [Current prevalence and characteristics of dermatoses associated with human immunodeficiency virus infection]. Actas Dermosifiliogr 2010; 101: 702-9.
4. Dunic I, Vesic S, Jevtovic DJ. Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy. HIV Med 2004;5:50-4.
5. Mathes BM, Douglass MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985;13:947-51.
6. Osei-Sekyere B, Karstaedt AS. Immune reconstitution inflammatory syndrome involving the skin. Clin Exp Dermatol 2010;35:477-81.
7. Burton JL, Pye RJ. Seborrhoea is not a feature of seborrhoeic dermatitis. Br Med J (Clin Res Ed). 1983; 286: 1169-70.
8. Tajima M, Sugita T, Nishikawa A, et al. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol 2008;128:345-51.
9. DeAngelis YM, Gemmer CM, Kaczvinsky JR, et al. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J Investig Dermatol Symp Proc 2005;10:295-7.
10. Pierard-Franchimont C, Pierard GE, Arrese JE, et al. Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments. Dermatology 2001;202:171-6.
11. Pierard-Franchimont C, Goffin V, Decroix J, et al. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol 2002;15:434-41.
12. Danby FW, Maddin WS, Margesson LJ, et al. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993;29:1008-12.
13. Gupta AK, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol 2014;28:16-26.
14. Lambert DR, Siegle RJ, Camisa C. Griseofulvin and ketoconazole in the treatment of dermatophyte infections. Int J Dermatol 1989;28:300-4.
15. Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN. Topical antifungals for seborrhoeic dermatitis. Cochrane Database Syst Rev 2015: CD008138.
16. Kastarinen H, Oksanen T, Okokon EO, et al. Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp. Cochrane Database Syst Rev 2014:CD009446.
17. Lebwohl M. Psoriasis. Lancet 2003;361:1197-204.
18. Sola-Ortigosa J, Sanchez-Regana M, UmbertMillet P. [An update on scalp psoriasis]. Actas Dermosifiliogr 2009; 100: 536-43.
19. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patientmembership survey. Arch Dermatol 2001; 137:280-4.
20. Ortonne J, Chimenti S, Luger T, et al. Scalp psoriasis: European consensus on grading and treatment algorithm. J Eur Acad Dermatol Venereol 2009; 23: 1435-44.
21. George SM, Taylor MR, Farrant PB. Psoriatic alopecia. Clin Exp Dermatol 2015;40:717-21.
22. Cockayne SE, Messenger AG. Familial scarring alopecia associated with scalp psoriasis. Br J Dermatol 2001;144:425-7.
23. Kim GW, Jung HJ, Ko HC, et al. Dermoscopy can be useful in differentiating scalp psoriasis from seborrhoeic dermatitis. Br J Dermatol 2011; 164: 652-6.
24. Kibar M, Aktan S, Bilgin M. Dermoscopic findings in scalp psoriasis and seborrheic dermatitis; two new signs; signet ring vessel and hidden hair. Indian J Dermatol 2015;60:41-5.
25. Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol 2006;55:799-806.
26. Iamsumang W, Sriphojanart T, Suchonwanit P. Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus. Case Rep Dermatol 2017;9:51-9.
27. Wang TS, Tsai TF. Managing Scalp Psoriasis: An Evidence-Based Review. Am J Clin Dermatol 2017; 18:17-43.
28. Dermatological Society of Thailand [Internet]. Clinical Practice Guideline for Psoriasis 2011; 2011 [cited 2017 Dec 16]. Available from: https://www.dst.or.th/Physician/Articles/435.29.0/ yYLY4tzYM0.
29. Puig L, Ribera M, Hernanz JM, et al. [Treatment of scalp psoriasis: review of the evidence and Delphi consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology]. Actas Dermosifiliogr 2010; 101: 827-46.
30. Schlager JG, Rosumeck S, Werner RN, et al. Topical treatments for scalp psoriasis. Cochrane Database Syst Rev 2016;2:CD009687.
31. Fotiadou C, Lazaridou E, Sotiriou E, et al. Scalp psoriasis and biologic agents: a retrospective, comparative study from a tertiary psoriasis referral centre. J Eur Acad Dermatol Venereol. 2016; 30: 2091-6.
32. Hay RJ. Tinea Capitis: Current Status. Mycopathologia. 2017; 182: 87-93.
33. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol 2000; 42: 1-20; quiz 1-4.
34. Fuller LC, Barton RC, Mohd Mustapa MF, et al. British Association of Dermatologists' guidelines for the management of tinea capitis 2014. Br J Dermatol 2014;171:454-63.
35. Ekiz O, Sen BB, Rifaioglu EN, Balta I. Trichoscopy in paediatric patients with tinea capitis: a useful method to differentiate from alopecia areata. J Eur Acad Dermatol Venereol 2014;28:1255-8.
36. Slowinska M, Rudnicka L, Schwartz RA, et al. Comma hairs: a dermatoscopic marker for tinea capitis: a rapid diagnostic method. J Am Acad Dermatol 2008; 59:S77-9.
37. Neri I, Starace M, Patrizi A, Balestri R. Corkscrew hair: a trichoscopy marker of tinea capitis in an adult white patient. JAMA Dermatol 2013;149:990-1.
38. Lacarrubba F, Verzi AE, Micali G. Newly described features resulting from high-magnification dermoscopy of tinea capitis. JAMA Dermatol 2015;151:308-10.
39. Wang HH, Lin YT. Bar code-like hair: dermoscopic marker of tinea capitis and tinea of the eyebrow. J Am Acad Dermatol 2015;72:S41-2.
40. Dermatological Society of Thailand [Internet]. Clinical Practice Guideline Superficial Fungal Infection 2011; 2011 [cited 2017 Dec 16]. Available from: https://www.dst.or.th/Physician/Articles/433.29.0/ 5LNWbWTDDb.
41. Chen X, Jiang X, Yang M, et al. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2016:CD004685.
42. Tey HL, Tan AS, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol 2011;64:663- 70.
43. Koumantaki-Mathioudaki E, DevliotouPanagiotidou D, Rallis E, et al. Is itraconazole the treatment of choice in Microsporum canis tinea capitis? Drugs Exp Clin Res 2005; 31:11-5.
44. Proudfoot LE, Higgins EM, Morris-Jones R. A retrospective study of the management of pediatric kerion in Trichophyton tonsurans infection. Pediatr Dermatol 2011;28:655-7.
45. Hussain I, Muzaffar F, Rashid T, et al. A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Med Mycol 1999;37:97-9.
46. Nenoff P, Kruger C, Paasch U, Ginter-Hanselmayer G. Mycology-an update Part 3: Dermatomycoses: topical and systemic therapy. J Dtsch Dermatol Ges 2015;13:387-410; quiz 441.
47. Kakourou T, Uksal U. Guidelines for the management of tinea capitis in children. Pediatr Dermatol 2010;27:226-8.
48. Goh CL. Eczema of the face, scalp and neck: an epidemiological comparison by site. J Dermatol 1989;16:223-6.
49. Hillen U, Grabbe S, Uter W. Patch test results in patients with scalp dermatitis: analysis of data of the Information Network of Departments of Dermatology. Contact Dermatitis 2007;56:87-93.
50. Knight AG. Pityriasis amiantacea: a clinical and histopathological investigation. Clin Exp Dermatol 1977;2:137-43.
51. McGinley KJ, Leyden JJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in nondandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol 1975;64:401-5.
52. Abdel-Hamid IA, Agha SA, Moustafa YM, EILabban AM. Pityriasis amiantacea: a clinical and etiopathologic study of 85 patients. Int J Dermatol 2003;42:260-4.
ดาวน์โหลด
เผยแพร่แล้ว
2017-12-01
รูปแบบการอ้างอิง
Harnchoowong, S., Suchonwanit, P., & Khunkhet, S. (2017). แนวทางเชิงปฏิบัติในการวินิจฉัยและดูแลรักษาภาวะหนังศีรษะเป็นขุย. วารสารโรคผิวหนัง, 33(4), 239–257. สืบค้น จาก https://he02.tci-thaijo.org/index.php/TJD/article/view/159077
ฉบับ
ประเภทบทความ
บทความฟื้นฟูวิชาการ
สัญญาอนุญาต
เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสาร ไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใดๆ
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นลิขสิทธิ์ของวารสารฯ หากบุคคลหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใดๆ จะต้องได้รับอนุญาตเป็นลายลักอักษรจากบรรณาธิการวารสารโรคผิวหนังก่อนเท่านั้น
